Chad A Bousman (C A Bousman, Chad Bousman)

ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 48

Top Topics

Systematic Review

Prefrontal Cortex

Major Depressive Disorder

Top Venues

CPT: pharmacometrics & systems pharmacology

Clinical pharmacology and therapeutics

Molecular psychiatry

This page only lists publications with an associated author ORCID identifier.

Publications

Abdullah Al Maruf, Meagan Shields, Amber Fryza, Amanda Wondrasek, Christine Leong, Kaarina Kowalec, Chad A Bousman
Knowledge and perceptions of pharmacogenomics among pharmacists in Manitoba, Canada. Pharmacogenomics (2024)
Diogo Marques, Nazanin Vaziri, Steven C Greenway, Chad A Bousman
DNA methylation and histone modifications associated with antipsychotic treatment: a systematic review. Molecular psychiatry (2024)
Abdullah Al Maruf, Meagan Shields, Amber Fryza, Amanda Wondrasek, Christine Leong, Kaarina Kowalec, Chad A Bousman
Knowledge and perceptions of pharmacogenomics among pharmacists in Manitoba, Canada. Pharmacogenomics 25 (4) (2024)
Sam Mostafa, Reza Rafizadeh, Thomas M Polasek, Chad A Bousman, Amin Rostami-Hodjegan, Robert M Stowe, Prescilla Carrion, Leslie J Sheffield, Carl M J Kirkpatrick
Virtual twins for model-informed precision dosing of clozapine in patients with treatment-resistant schizophrenia. CPT: pharmacometrics & systems pharmacology 13 (3) (2024)
Sam Mostafa, Reza Rafizadeh, Thomas M Polasek, Chad A Bousman, Amin Rostami-Hodjegan, Robert M Stowe, Prescilla Carrion, Leslie J Sheffield, Carl M J Kirkpatrick
Virtual twins for model-informed precision dosing of clozapine in patients with treatment-resistant schizophrenia. CPT: pharmacometrics & systems pharmacology (2024)
Kanika Bharthi, Rayyan Zuberi, Abdullah Al Maruf, Sarker M Shaheen, Ryden McCloud, Madison Heintz, Laina McAusland, Paul D Arnold, Chad A Bousman
Impact of Cytochrome P450 Genetic Variation on Patient-Reported Symptom Improvement and Side Effects Among Children and Adolescents Treated with Fluoxetine. Journal of child and adolescent psychopharmacology 34 (1) (2024)
Sam Mostafa, Reza Rafizadeh, Thomas M Polasek, Chad A Bousman, Amin Rostami-Hodjegan, Robert M Stowe, Prescilla Carrion, Leslie J Sheffield, Carl M J Kirkpatrick
Virtual twins for model-informed precision dosing of clozapine in patients with treatment-resistant schizophrenia. CPT: pharmacometrics & systems pharmacology 13 (3) (2024)
Sam Mostafa, Reza Rafizadeh, Thomas M Polasek, Chad A Bousman, Amin Rostami-Hodjegan, Robert M Stowe, Prescilla Carrion, Leslie J Sheffield, Carl M J Kirkpatrick
Virtual twins for model-informed precision dosing of clozapine in patients with treatment-resistant schizophrenia. CPT: pharmacometrics & systems pharmacology 13 (3) (2024)
Kanika Bharthi, Rayyan Zuberi, Abdullah Al Maruf, Sarker M Shaheen, Ryden McCloud, Madison Heintz, Laina McAusland, Paul D Arnold, Chad A Bousman
Impact of Cytochrome P450 Genetic Variation on Patient-Reported Symptom Improvement and Side Effects Among Children and Adolescents Treated with Fluoxetine. Journal of child and adolescent psychopharmacology 34 (1) (2024)
Abdullah Al Maruf, Meagan Shields, Amber Fryza, Amanda Wondrasek, Christine Leong, Kaarina Kowalec, Chad A Bousman
Knowledge and perceptions of pharmacogenomics among pharmacists in Manitoba, Canada. Pharmacogenomics 25 (4) (2024)
Brandon-Joe Cilia, Dhamidhu Eratne, Cassandra M J Wannan, Charles B Malpas, Shorena Janelidze, Oskar Hansson, Ian Everall, Chad A Bousman, Naveen Thomas, Alexander F Santillo, Dennis Velakoulis, Christos Pantelis
Associations between structural brain changes and blood neurofilament light chain protein in treatment-resistant schizophrenia. medRxiv : the preprint server for health sciences (2024)
Brandon-Joe Cilia, Dhamidhu Eratne, Cassandra M J Wannan, Charles B Malpas, Shorena Janelidze, Oskar Hansson, Ian Everall, Chad A Bousman, Naveen Thomas, Alexander F Santillo, Dennis Velakoulis, Christos Pantelis
Associations between structural brain changes and blood neurofilament light chain protein in treatment-resistant schizophrenia. medRxiv : the preprint server for health sciences (2024)
Sam Mostafa, Reza Rafizadeh, Thomas M Polasek, Chad A Bousman, Amin Rostami-Hodjegan, Robert M Stowe, Prescilla Carrion, Leslie J Sheffield, Carl M J Kirkpatrick
Virtual twins for model-informed precision dosing of clozapine in patients with treatment-resistant schizophrenia. CPT: pharmacometrics & systems pharmacology 13 (3) (2024)
Sam Mostafa, Reza Rafizadeh, Thomas M Polasek, Chad A Bousman, Amin Rostami-Hodjegan, Robert M Stowe, Prescilla Carrion, Leslie J Sheffield, Carl M J Kirkpatrick
Virtual twins for model-informed precision dosing of clozapine in patients with treatment-resistant schizophrenia. CPT: pharmacometrics & systems pharmacology 13 (3) (2024)
Amit Lotan, Sandra Luza, Carlos M Opazo, Scott Jonathan Ayton, Darius J R Lane, Serafino Mancuso, Avril Pereira, Suresh Sundram, Cynthia Shannon Weickert, Chad A Bousman, Christos Pantelis, Ian P Everall, Ashley I Bush
Perturbed iron biology in the prefrontal cortex of people with schizophrenia. Molecular psychiatry (2023)
Leen Magarbeh, Claudia Hassel, Maximilian Choi, Farhana Islam, Victoria S Marshe, Clement C Zai, Rayyan Zuberi, Roseann S Donnelly, Xiaoyu Men, Maike Scherf-Clavel, Dietmar Enko, Benicio N Frey, Roumen V Milev, Claudio N Soares, Sagar V Parikh, Franca Placenza, Stephen C Strother, Stefanie Hassel, Valerie H Taylor, Francesco Leri, Pierre Blier, Faranak Farzan, Raymond W Lam, Gustavo Turecki, Jane A Foster, Susan Rotzinger, Stefan Kloiber, James L Kennedy, Sidney H Kennedy, Chad A Bousman, Daniel J Müller
ABCB1 gene variants and Antidepressant Treatment Outcomes: A Systematic Review and Meta-analysis including results from the CAN-BIND-1 Study. Clinical pharmacology and therapeutics (2023)
Chaten D Jessel, Ankita Narang, Rayyan Zuberi, Chad A Bousman
Sleep Quality and Duration in Children That Consume Caffeine: Impact of Dose and Genetic Variation in ADORA2A and CYP1A . Genes 14 (2) (2023)
Malcolm Peter Forbes, Malcolm Hopwood, Chad A Bousman
CYP2D6 and CYP2C19 Variant Coverage of Commercial Antidepressant Pharmacogenomic Testing Panels Available in Victoria, Australia. Genes 14 (10) (2023)
Chaten D Jessel, Ankita Narang, Rayyan Zuberi, Chad A Bousman
Sleep Quality and Duration in Children That Consume Caffeine: Impact of Dose and Genetic Variation in ADORA2A and CYP1A . Genes 14 (2) (2023)
Suriati Mohamed Saini, Chad A Bousman, Serafino G Mancuso, Vanessa L Cropley, Tamsyn E Van Rheenen, Rhoshel K Lenroot, Jason Bruggemann, Cynthia S Weickert, Thomas W Weickert, Suresh Sundram, Ian P Everall, Christos Pantelis
Genetic variation in glutamatergic genes moderates the effects of childhood adversity on brain volume and IQ in treatment-resistant schizophrenia. Schizophrenia (Heidelberg, Germany) 9 (1) (2023)
Amy J Turner, Charity Nofziger, Bronwyn E Ramey, Reynold C Ly, Chad A Bousman, José A G Agúndez, Katrin Sangkuhl, Michelle Whirl-Carrillo, Simone Vanoni, Henry M Dunnenberger, Gualberto Ruano, Martin A Kennedy, Michael S Phillips, Houda Hachad, Teri E Klein, Ann M Moyer, Andrea Gaedigk
PharmVar Tutorial on CYP2D6 Structural Variation Testing and Recommendations on Reporting. Clinical pharmacology and therapeutics (2023)
Amit Lotan, Sandra Luza, Carlos M Opazo, Scott Jonathan Ayton, Darius J R Lane, Serafino Mancuso, Avril Pereira, Suresh Sundram, Cynthia Shannon Weickert, Chad A Bousman, Christos Pantelis, Ian P Everall, Ashley I Bush
Perturbed iron biology in the prefrontal cortex of people with schizophrenia. Molecular psychiatry (2023)
Sibel Saya, Patty Chondros, Anastasia Gardner, Cathrine Mihalopolous, Mary Lou Chatterton, Jane Maree Gunn, Timothy Frank Chen, Thomas M Polasek, Elise Dettmann, Rachel Brooks, Michelle King, Luke Spencer, Pavithran Alphonse, Shakira R Onwuka, Georgia Ramsay, Zoe Siviour, Jamie Jm Liew, Philip Ly, Matthew Thoenig, Raushaan Seychell, Floriana La Rocca, Luke B Hesson, Nydia Mejias, Terri Sivertsen, Melanie Anne Galea, Chad A Bousman, Jon David Emery
The PRESIDE (PhaRmacogEnomicS In DEpression) Trial: a double-blind randomised controlled trial of pharmacogenomic-informed prescribing of antidepressants on depression outcomes in patients with major depressive disorder in primary care. Trials 24 (1) (2023)
Karen M Savage, Jerome Sarris, Matthew Hughes, Chad A Bousman, Susan Rossell, Andrew Scholey, Con Stough, Chao Suo
Neuroimaging Insights: Kava's ( Piper methysticum ) Effect on Dorsal Anterior Cingulate Cortex GABA in Generalized Anxiety Disorder. Nutrients 15 (21) (2023)
Chaten D Jessel, Ankita Narang, Rayyan Zuberi, Chad A Bousman
Sleep Quality and Duration in Children That Consume Caffeine: Impact of Dose and Genetic Variation in ADORA2A and CYP1A . Genes 14 (2) (2023)
Sibel Saya, Patty Chondros, Anastasia Gardner, Cathrine Mihalopolous, Mary Lou Chatterton, Jane Maree Gunn, Timothy Frank Chen, Thomas M Polasek, Elise Dettmann, Rachel Brooks, Michelle King, Luke Spencer, Pavithran Alphonse, Shakira R Onwuka, Georgia Ramsay, Zoe Siviour, Jamie Jm Liew, Philip Ly, Matthew Thoenig, Raushaan Seychell, Floriana La Rocca, Luke B Hesson, Nydia Mejias, Terri Sivertsen, Melanie Anne Galea, Chad A Bousman, Jon David Emery
The PRESIDE (PhaRmacogEnomicS In DEpression) Trial: a double-blind randomised controlled trial of pharmacogenomic-informed prescribing of antidepressants on depression outcomes in patients with major depressive disorder in primary care. Trials 24 (1) (2023)
Chaten D Jessel, Ankita Narang, Rayyan Zuberi, Chad A Bousman
Sleep Quality and Duration in Children That Consume Caffeine: Impact of Dose and Genetic Variation in ADORA2A and CYP1A . Genes 14 (2) (2023)
Lisa C Brown, William V Bobo, Cory A Gall, Daniel J Müller, Chad A Bousman
Pharmacomicrobiomics of Antidepressants in Depression: A Systematic Review. Journal of personalized medicine 13 (7) (2023)
Leen Magarbeh, Claudia Hassel, Maximilian Choi, Farhana Islam, Victoria S Marshe, Clement C Zai, Rayyan Zuberi, Roseann S Donnelly, Xiaoyu Men, Maike Scherf-Clavel, Dietmar Enko, Benicio N Frey, Roumen V Milev, Claudio N Soares, Sagar V Parikh, Franca Placenza, Stephen C Strother, Stefanie Hassel, Valerie H Taylor, Francesco Leri, Pierre Blier, Faranak Farzan, Raymond W Lam, Gustavo Turecki, Jane A Foster, Susan Rotzinger, Stefan Kloiber, James L Kennedy, Sidney H Kennedy, Chad A Bousman, Daniel J Müller
ABCB1 Gene Variants and Antidepressant Treatment Outcomes: A Systematic Review and Meta-Analysis Including Results from the CAN-BIND-1 Study. Clinical pharmacology and therapeutics (2023)
Sibel Saya, Patty Chondros, Anastasia Gardner, Cathrine Mihalopolous, Mary Lou Chatterton, Jane Maree Gunn, Timothy Frank Chen, Thomas M Polasek, Elise Dettmann, Rachel Brooks, Michelle King, Luke Spencer, Pavithran Alphonse, Shakira R Onwuka, Georgia Ramsay, Zoe Siviour, Jamie Jm Liew, Philip Ly, Matthew Thoenig, Raushaan Seychell, Floriana La Rocca, Luke B Hesson, Nydia Mejias, Terri Sivertsen, Melanie Anne Galea, Chad A Bousman, Jon David Emery
The PRESIDE (PhaRmacogEnomicS In DEpression) Trial: a double-blind randomised controlled trial of pharmacogenomic-informed prescribing of antidepressants on depression outcomes in patients with major depressive disorder in primary care. Trials 24 (1) (2023)
Chad A Bousman, Abdullah Al Maruf, Diogo Ferri Marques, Lisa C Brown, Daniel J Müller
The emergence, implementation, and future growth of pharmacogenomics in psychiatry: a narrative review. Psychological medicine (2023)
Amit Lotan, Sandra Luza, Carlos M Opazo, Scott Jonathan Ayton, Darius J R Lane, Serafino Mancuso, Avril Pereira, Suresh Sundram, Cynthia Shannon Weickert, Chad A Bousman, Christos Pantelis, Ian P Everall, Ashley I Bush
Perturbed iron biology in the prefrontal cortex of people with schizophrenia. Molecular psychiatry (2023)
Chad A Bousman, James M Stevenson, Laura B Ramsey, Katrin Sangkuhl, J Kevin Hicks, Jeffrey A Mills, Ajeet B Singh, Gualberto Ruaño, Daniel J Mueller, Evangelia Eirini Tsermpini, Jacob T Brown, Gillian C Bell, James Steven Leeder, Andrea Gaedigk, Stuart A Scott, Teri E Klein, Kelly E Caudle, Jeffrey R Bishop
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants. Clinical pharmacology and therapeutics (2023)
Ankita Narang, Paul Lacaze, Kathlyn J Ronaldson, John J McNeill, Mahesh Jayaram, Naveen Thomas, Rory Sellmer, David N Crockford, Robert Stowe, Steven C Greenway, Christos Pantelis, Chad A Bousman
Whole-genome sequencing analysis of clozapine-induced myocarditis. The pharmacogenomics journal 22 (3) (2022)
Abdullah Al Maruf, Chad A Bousman
Approaches and hurdles of implementing pharmacogenetic testing in the psychiatric clinic. PCN reports : psychiatry and clinical neurosciences 1 (2) (2022)
Meagan Hayashi, Chad A Bousman
Experience, Knowledge, and Perceptions of Pharmacogenomics among Pharmacists and Nurse Practitioners in Alberta Hospitals. Pharmacy (Basel, Switzerland) 10 (6) (2022)
Lisa C Brown, Joseph D Stanton, Kanika Bharthi, Abdullah Al Maruf, Daniel J Müller, Chad A Bousman
Pharmacogenomic Testing and Depressive Symptom Remission: A Systematic Review and Meta-Analysis of Prospective, Controlled Clinical Trials. Clinical pharmacology and therapeutics 112 (6) (2022)
Jose De Leon, Georgios Schoretsanitis, Robert Løvsletten Smith, Espen Molden, Anssi Solismaa, Niko Seppälä, Miloslav Kopeček, Patrik Švancer, Ismael Olmos, Carina Ricciardi, Celso Iglesias-Garcia, Ana Iglesias-Alonso, Edoardo Spina, Can-Jun Ruan, Chuan-Yue Wang, Gang Wang, Yi-Lang Tang, Shih Ku Lin, Hsien-Yuan Lane, Yong Sik Kim, Se Hyun Kim, Anto P Rajkumar, Dinora Fabiola González Esquivel, Helgi Jung-Cook, Trino Baptista, Christopher Rohde, Jimmi Nielsen, Hélène Verdoux, Clelia Quiles, Emílio J Sanz, Carlos de Las Cuevas, Dan Cohen, Peter F J Schulte, Aygün Ertuğrul, Elif Anıl Yağcıoğlu, Nitin Chopra, Betsy McCollum, Charles Shelton, Robert O Cotes, Arun R Kaithi, John M Kane, Saeed Farooq, Chee H Ng, John Bilbily, Christoph Hiemke, Carlos López-Jaramillo, Ian R McGrane, Fernando Lana, Chin Bin Eap, Manuel Arrojo-Romero, Flavian Ş Rădulescu, Erich Seifritz, Susanna Every-Palmer, Chad A Bousman, Emmanuel Bebawi, Rahul Bhattacharya, Deanna L Kelly, Yuji Otsuka, Judit Lazary, Rafael Torres, Agustin Yecora, Mariano Motuca, Kit Wa Sherry Chan, Monica Zolezzi, Sami Ouanes, Domenico de Berardis, Sandeep Grover, Ric M Procyshyn, Richard A Adebayo, Oleg O Kirilochev, Andrey Soloviev, Konstantinos N Fountoulakis, Alina Wilkowska, Wiesław Jerzy Cubała, Muhammad Ayub, Alzira Silva, Raphael M Bonelli, Jose M Villagrán-Moreno, Jacqueline Mayoral-van Son, Henk S Temmingh, Eric H Decloedt, Maria R Pedro, Hiroyoshi Takeuchi, Masaru Tsukahara, Gerhard Gründer, Marina Šagud, Andreja Celofiga, Dragana Ignjatovic Ristic, Bruno B Ortiz, Helio Elkis, Antônio Pacheco Palha, Adrián LLerena, Emilio Fernandez-Egea, Dan J Siskind, Abraham Weizman, Rim Masmoudi, Shamin Mohd Saffian, Jonathan G Leung, Peter F Buckley, Stephen R Marder, Citrome Leslie, Oliver Freudenreich, Christoph U Correll, Daniel J Mueller
Correction: An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels. Pharmacopsychiatry 55 (2) (2022)
Sam Mostafa, Thomas M Polasek, Chad A Bousman, Daniel J Mueller, Leslie J Sheffield, Joel Rembach, Carl M J Kirkpatrick
Pharmacogenomics in psychiatry - the challenge of cytochrome P450 enzyme phenoconversion and solutions to assist precision dosing. Pharmacogenomics 23 (15) (2022)
Lisa Tl Ying, Mark C Yarema, Chad A Bousman
Dispensing patterns of mental health medications before and during the COVID-19 pandemic in Alberta, Canada: An interrupted time series analysis. International journal of psychiatry in medicine (2022)
Cynthia Okhuijsen-Pfeifer, Marte van der Horst, Chad A Bousman, B Lin, K R van Eijk, S Ripke, Y Ayhan, M O Babaoglu, M Bak, W Alink, H van Beek, E Beld, A Bouhuis, M Edlinger, I M Erdogan, A Ertuğrul, G Yoca, I P Everall, T Görlitz, null null, K P Grootens, S Gutwinski, T Hallikainen, E Jeger-Land, M de Koning, Markku Lähteenvuo, Sophie E Legge, S Leucht, C Morgenroth, A Müderrisoğlu, A Narang, Christos Pantelis, Antonio F Pardinas, T Oviedo-Salcedo, J Schneider-Thoma, S Schreiter, E Repo-Tiihonen, H Tuppurainen, M Veereschild, S Veerman, M de Vos, Elias Wagner, D Cohen, Jan P A M Bogers, J T R Walters, A E Anil Yağcıoğlu, Jari Tiihonen, A Hasan, Jurjen J Luykx
Genome-wide association analyses of symptom severity among clozapine-treated patients with schizophrenia spectrum disorders. Translational psychiatry 12 (1) (2022)
Abdullah Al Maruf, Chad A Bousman
Approaches and hurdles of implementing pharmacogenetic testing in the psychiatric clinic. PCN reports : psychiatry and clinical neurosciences 1 (2) (2022)
Chad A Bousman, Gouri Mukerjee, Xiaoyu Men, Ruslan Dorfman, Daniel J Müller, Roger E Thomas
Encountering Pharmacogenetic Test Results in the Psychiatric Clinic. Canadian journal of psychiatry. Revue canadienne de psychiatrie (2021)
Lara E Murphy, Trehani M Fonseka, Chad A Bousman, Daniel J Mueller
Gene-drug pairings for antidepressants and antipsychotics: level of evidence and clinical application. Molecular psychiatry (2021)
Jose De Leon, Georgios Schoretsanitis, Robert Løvsletten Smith, Espen Molden, Anssi Solismaa, Niko Seppälä, Miloslav Kopeček, Patrik Švancer, Ismael Olmos, Carina Ricciardi, Celso Iglesias-Garcia, Ana Iglesias-Alonso, Edoardo Spina, Can-Jun Ruan, Chuan-Yue Wang, Gang Wang, Yi-Lang Tang, Shih Ku Lin, Hsien-Yuan Lane, Yong Sik Kim, Se Hyun Kim, Anto P Rajkumar, Dinora Fabiola González Esquivel, Helgi Jung-Cook, Trino Baptista, Christopher Rohde, Jimmi Nielsen, Hélène Verdoux, Clelia Quiles, Emílio J Sanz, Carlos de Las Cuevas, Dan Cohen, Peter F J Schulte, Aygün Ertuğrul, Elif Anıl Yağcıoğlu, Nitin Chopra, Betsy McCollum, Charles Shelton, Robert O Cotes, Arun R Kaithi, John M Kane, Saeed Farooq, Chee H Ng, John Bilbily, Christoph Hiemke, Carlos López-Jaramillo, Ian R McGrane, Fernando Lana, Chin Bin Eap, Manuel Arrojo-Romero, Flavian Ş Rădulescu, Erich Seifritz, Susanna Every-Palmer, Chad A Bousman, Emmanuel Bebawi, Rahul Bhattacharya, Deanna L Kelly, Yuji Otsuka, Judit Lazary, Rafael Torres, Agustin Yecora, Mariano Motuca, Kit Wa Sherry Chan, Monica Zolezzi, Sami Ouanes, Domenico de Berardis, Sandeep Grover, Ric M Procyshyn, Richard A Adebayo, Oleg O Kirilochev, Andrey Soloviev, Konstantinos N Fountoulakis, Alina Wilkowska, Wiesław Jerzy Cubała, Muhammad Ayub, Alzira Silva, Raphael M Bonelli, Jose M Villagrán-Moreno, Jacqueline Mayoral-van Son, Henk S Temmingh, Eric H Decloedt, Maria R Pedro, Hiroyoshi Takeuchi, Masaru Tsukahara, Gerhard Gründer, Marina Šagud, Andreja Celofiga, Dragana Ignjatovic Ristic, Bruno B Ortiz, Helio Elkis, Antônio Pacheco Palha, Adrián LLerena, Emilio Fernandez-Egea, Dan J Siskind, Abraham Weizman, Rim Masmoudi, Shamin Mohd Saffian, Jonathan G Leung, Peter F Buckley, Stephen R Marder, Citrome Leslie, Oliver Freudenreich, Christoph U Correll, Daniel J Mueller
An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels. Pharmacopsychiatry 55 (2) (2021)
Abdullah Al Maruf, Mikayla Fan, Paul D Arnold, Daniel J Müller, Katherine Aitchison, Chad A Bousman
Reply to Dawes et al. Canadian journal of psychiatry. Revue canadienne de psychiatrie 65 (8) (2020)
Abdullah Al Maruf, Mikayla Fan, Paul D Arnold, Daniel J Müller, Katherine J Aitchison, Chad A Bousman
Pharmacogenetic Testing Options Relevant to Psychiatry in Canada: Options de tests pharmacogénétiques pertinents en psychiatrie au Canada. Canadian journal of psychiatry. Revue canadienne de psychiatrie 65 (8) (2020)
Lachlan Cribb, Jenifer Murphy, Amy Froud, Georgina Oliver, Chad A Bousman, Chee H Ng, Jerome Sarris
Erythrocyte polyunsaturated fatty acid composition is associated with depression and FADS genotype in Caucasians. Nutritional neuroscience 21 (8) (2017)